Vaping cessation has emerged as a critical health focus, particularly among teens and young adults grappling with nicotine addiction.This demographic faces unique challenges, as evidenced by a recent study published in JAMA, which highlights the efficacy of varenicline, an FDA-approved smoking cessation pill.